RecruitingPhase 4NCT06653634

Optimizing Treatment for Patients With Juvenile Idiopathic Arthritis in Sustained Remission: The MOVE-JIA Trial

Studying Juvenile idiopathic arthritis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Oslo University Hospital
Principal Investigator
Anna-Birgitte Aga, MD PhD
Oslo University Hospital
Intervention
Methotrexate(drug)
Enrollment
150 target
Eligibility
2-17 years · All sexes
Timeline
20242029

Study locations (7)

Collaborators

The Research Council of Norway · South-Eastern Norway Regional Health Authority · Remedy

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06653634 on ClinicalTrials.gov

Other trials for Juvenile idiopathic arthritis

Additional recruiting or active studies for the same condition.

See all trials for Juvenile idiopathic arthritis

← Back to all trials